Benign breast disease I: hormonal investigation

Area of Science:

• Endocrinology
• Reproductive Biology
• Oncology

Background:

• Benign breast disease (BBD) affects a significant number of women.
• Hormonal fluctuations, particularly during the menstrual cycle, are implicated in BBD development.
• Understanding corpus luteum function is crucial for BBD research.

Purpose of the Study:

• To investigate corpus luteum function in women with benign breast disease.
• To compare hormonal profiles, specifically progesterone and estradiol levels, between BBD patients and healthy controls.
• To identify potential endocrine factors contributing to BBD.

Main Methods:

• Studied 184 women with BBD and 50 healthy women with confirmed ovulatory cycles.
• Assessed corpus luteum function via plasma progesterone (P) and estradiol (E2) measurements.
• Collected hormone samples on days 5, 7, and 9 of the hyperthermic phase of the luteal phase.

Main Results:

• Women with BBD exhibited a significantly lower plasma progesterone to estradiol ratio during the luteal phase compared to controls.
• Plasma progesterone levels were consistently lower in all BBD patient groups.
• Patients with adenosis tumors and increased breast nodularity showed normal or elevated plasma estradiol levels.

Conclusions:

• An imbalance in estradiol and progesterone secretion by the corpus luteum is a consistent finding in women with benign breast disease.
• This hormonal imbalance may be a key factor in the pathogenesis of BBD.
• Further research into luteal phase defects could offer new therapeutic targets for BBD.